SUBSCRIBE
SUBSCRIBE

Protalix Biotherapeutics, Inc. to Present at Three Upcoming Healthcare Conferences

May 29, 2012 | 
1 min read

CARMIEL, Israel, May 29, 2012 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE Amex:PLX) (TASE:PLX), today announced that senior management will present at three upcoming conferences.

Events Asia
MORE ON THIS TOPIC
Facade of AstraZeneca's office in Shanghai, China
Mergers & acquisitions
AstraZeneca Buys FibroGen’s China Unit for $160M as Probes Continue
February 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone business concept collage. Idea concept, business concept, financial planning,financial profit, favorable conditions, favorable conditions. Trendy modern retro illustration in bright trendy colors. Vector illustration
Mergers & acquisitions
Bain Bets Big on Japanese Market With $3.3B Tanabe Buy
February 10, 2025
 · 
1 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Rare diseases
AceLink’s Fabry Hopeful Shows Potential in Mid-Stage Study
February 10, 2025
 · 
2 min read
 · 
Tristan Manalac
vial of vaccine for the vaccination plan against diseases in the China. Doctor with a vial with doses of the vaccine in front of the China flag
Earnings
Merck’s Gardasil Woes Grow as China Trade War Heats Up
February 4, 2025
 · 
4 min read
 · 
Annalee Armstrong